PT 211: Pharmacology for Physical Therapists for Winter/Spring 2016
Section outline
-
Course director: Tina Brock, BSPharm, MS, EdD Office: S953 Parnassus
Course personnel:
Laurel Carmichael, P3
Dario Nassif, P1
Brandon Conley, P2
Liz Staub, P3
Allison Komerinko, PharmD
Daryush Tabatabai, P3
Uche Mordi, P1
Sheri Van Osdol, PharmD
Scott Myers, P1
-
Course Introduction: Pharmacologic Principles for the Physical Therapist - HSW302 - March 3, 9:30-10:15 am
Course Director: Tina Brock
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Navigate to the course website for detailed course information.
- Compare the common goals of pharmacotherapy and physical therapy treatments.
- Differentiate between class name, chemical name, generic name, and brand/trade name for prescription and over-the-counter (OTC) medicines.
- Discuss generalities of how medicines may influence, or be influenced by, physical therapy treatments.
-
Instructor: Allison Komirenko, PharmD
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Contrast pharmacokinetics (PK) and pharmacodynamics (PD), and be able to identify a drug-drug interaction as either PK or PD in nature.
- Contrast the terms agonist and antagonist as interpreted by pharmacists and by physical therapists.
- Define the ADME parameters and how these influence drug effects.
- Identify situations where therapeutic drug monitoring is needed.
-
Instructor: Sheri Van Osdol, PharmD
**NOTE - Please bring fully charged laptops or tablets for this session**
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Identify and recommend appropriate lay and professional resources for accessing information about medications.
- Use common professional resources to locate and interpret specific information about medicines.
- Guide both lay users and other health professionals to reliable sources of health information in cyberspace.
-
***Please sit in your assigned groups for this session and all subsequent sessions**
Discussion Leader: Brandon Conley, P2
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Differentiate treatment approaches for allergic rhinitis, asthma, and COPD.
- Distinguish between quick-relief and long-term control medications for asthma.
- Match the adverse effects (e.g., sedation, orthostatic hypotension, hypertension, tachycardia, osteoporosis) of common respiratory medicines that could interfere with physical therapy treatments.
- Demonstrate the appropriate support response in a patient experiencing an acute asthma attack.
-
Discussion Leader: Laurel Carmichael, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Describe the mechanism of action of key classes of diabetes medications
- Recognize adverse effects of medicines used in the management of diabetes, particularly those that can cause hypoglycemia
- Recognize medication-timing windows that may optimize the efficacy and benefit of physical therapy treatments
- Explain how to respond to a hypoglycemic emergency
-
Discussion Leader: Liz Staub, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Recognize the generic names of the representative drug(s) for each class of medication.
- Briefly describe the mechanism of action of each representative drug as it relates to the pathophysiology of the respective disease state.
- When presented with a patient's medication administration record, list the medication side effects to watch for during physical therapy sessions.
-
Discussion Leader: Daryush Tabatabai, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Recognize different classes of antiepileptic drugs (AEDs) that are used to treat focal vs. generalized seizures.
- Explain the advantages of optimized seizure control for physical therapy treatments
- Match the adverse effects of common antiepileptic drugs (e.g., sedation, dizziness, ataxia, osteoporosis) that could interfere with physical therapy treatments.
- Define status epilepticus and identify treatments indicated for seizure emergencies.
-
Discussion Leaders: Uche Mordi (P1), Scott Myers (P1), Dario Nassif (P1)
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Match common OTC medications with their proper indication for use.
- Compare and contrast nonsteroidal anti-inflammatory drugs (NSAIDs) with acetaminophen with regard to uses and precautions.
- Explain the therapeutic and side effects of common cold and allergy medications and sleep aids, and how these relate to physical therapy treatments.
- Identify reliable resources for information about supplement safety and efficacy.
-
Discussion Leader: Laurel Carmichael, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Describe the rationales for the use of (a) opioid agonists, (b) mixed agonist-antagonist opioids, and (c) pure antagonist opioids.
- Describe how different dosing forms/routes can influence achievement of pain control.
- Identify adverse opioid effects and management strategies.
- Explain the advantages of optimized pain control regimens for physical therapy treatment.
- Explain how adverse reactions to opioid drugs could clinically interfere with physical therapy treatments.
-
Discussion Leader: Daryush Tabatabai, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Explain the mechanism of action and important adverse effects of medications used to treat psychiatric and movement disorders.
- Recognize medication-timing windows that may optimize the efficacy and benefit of physical therapy treatments.
-
Discussion Leader: Liz Staub, P3
Learning Objectives
At the conclusion of this session, the learner will be able to:
- List the side effects of short- and long-term glucocorticoid use.
- Explain the advantages of bone strengthening (i.e., as enhanced by calcium/vitamin D, bisphosphonates, SERMs) for physical therapy treatments.
- Match the adverse effects (e.g., nausea, hot flushes) of common bone-strengthening agents that could interfere with physical therapy treatments.
-
During this session, PT student groups will present 5-minute summaries (no more than 3 slides) describing specific physical therapy treatments and potential medication-related concerns. In addition, pharmacy and physical therapy students who participated in a cross-profession shadowing experience will share what they learned.
Discussion Leaders: All PT and Pharm students
Learning Objectives
At the conclusion of this session, the learner will be able to:
- Describe common physical therapy treatments and how medications may interact with these.
- Describe how physical therapists and pharmacists can work together to improve patient care.
- Describe communication challenges that may exist between members of the healthcare team, and how these may be ameliorated.
-
One PowerPoint file per group, please!
-
Discussion Leader: P1 Team
Student groups will compete in a Jeopardy-style challenge covering all learning objectives in the course.
-
The final examination in this course will be a comprehensive, open-notes case that should be completed and submitted in your assigned groups (i.e., one case turned in per group). Please make sure that at least one member of your group brings a laptop or tablet with internet access to the session.
The case will be distributed on-site and it will include material not previously covered in the course. This is intentional, not to create a stressful environment, but rather to represent one reflective of what clinical practice will be like for you - therapies will improve and the specifics we've discussed this term will change. The savvy physical therapist will be able to negotiate these changes with finesse, using the skills and tools we've practiced to provide the best care for his/her patients.
Please review the article linked below in preparation. Although it was written about medical students, I believe it applies to physical therapy and pharmacy students as well.